Pfizer Inc
DUS:PFE
Pfizer Inc
DUS:PFE
Price:
22.92
EUR
-0.02%
Market Cap:
€130.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
Pfizer Inc
DUS:PFE
|
US |
|
P
|
Phihong Technology Co Ltd
TWSE:2457
|
TW |
|
Synovus Financial Corp
NYSE:SNV
|
US |
|
Schumag AG
F:SCM
|
DE |
|
Oil and Natural Gas Corporation Ltd
NSE:ONGC
|
IN |
|
Dynasty Gold Corp
XTSX:DYG
|
CA |
|
Quantum BioPharma Ltd
NASDAQ:QNTM
|
CA |
|
A
|
Atlas Consolidated Mining and Development Corp
OTC:ACMDY
|
PH |
|
M
|
Majuba Hill Copper Corp
CNSX:JUBA
|
CA |
|
Adani Power Ltd
BSE:533096
|
IN |
|
C
|
Caladrius Biosciences Inc
LSE:0HS8
|
US |
|
Shri Bajrang Alliance Ltd
BSE:526981
|
IN |
|
S
|
S2Medical AB (publ)
STO:S2M
|
SE |
|
NuGene International Inc
OTC:NUGN
|
US |
|
Lisi SA
OTC:LSIIF
|
FR |
|
Nippon Densetsu Kogyo Co Ltd
TSE:1950
|
JP |
|
Offcn Education Technology Co Ltd
SZSE:002607
|
CN |
|
Trip.com Group Ltd
HKEX:9961
|
CN |
|
N
|
Nusasiri PCL
SET:NUSA
|
TH |
|
Baticim Bati Anadolu Cimento Sanayii AS
IST:BTCIM.E
|
TR |
|
B
|
Bantas Bandirma Ambalaj Sanayi ve Ticaret AS
IST:BNTAS.E
|
TR |
|
C
|
China Merchants Bank Co Ltd
HKEX:3968
|
CN |
Multiples-Based Value
The
Multiples-Based Value for
Pfizer Inc (PFE)
under the Base Case is
hidden
EUR.
Compared with the current market price of 22.92 EUR, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PFE Multiples-Based Value
LOCKED
Multiples Across Competitors
PFE Competitors Multiples
Pfizer Inc Competitors
Pfizer Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Pfizer Inc
DUS:PFE
|
155.5B EUR | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
878.2B USD | 13.5 | 42.6 | 28.7 | 30.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
573B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.6 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232.5B GBP | 5.2 | 30 | 16.6 | 23.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.3B USD | 4.6 | 16.3 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.4B CHF | 5.1 | 20.7 | 12.8 | 16.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.8 | 8 | 9.3 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
88.4B GBP | 2.7 | 15.5 | 8.4 | 10.4 | |
| UK |
|
GSK plc
XETRA:GS71
|
101.5B EUR | 2.7 | 15.4 | 8.4 | 10.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
